Andrew Quon
Clinical Trials
- Not Recruiting Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
- Not Recruiting Correlation of PET-CT Studies With Serum Protein Analysis
- Not Recruiting Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
- Recruiting Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
- Recruiting Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
- Not Recruiting Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
- Not Recruiting Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
- Not Recruiting Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer
- Not Recruiting Pre-surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
- Not Recruiting Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT)
- Recruiting 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
- Recruiting FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
- Recruiting Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
- Recruiting Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
Help
Trial Administration